A new focus on dermatology, ophthalmology, and gastroenterology will pave ways for many untapped opportunities that Viatris can utilize with its scale and manufacturing power. We believe Viatris is in ...

Unichem Laboratories Ltd is an India-based pharmaceutical company ... which caters to Dermatology and Allied therapies. They also launched 27 new products in various therapeutic segments during ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo The number of sexually transmitted ...

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities. Andrew Ward ...

particularly with regard to issues and questions generally not addressed in TDDS product packaging. Some pharmaceutical company representatives declined to divulge their surname or provide the ...

The Professional Certificate in Product Management is for those who want to build on or formalize their training for product management roles, including: Early-career professionals with one to five ...

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.

While their first recommendation is usually to visit a medical professional who specializes in dermatology, OTC products can treat some mild acne types. For moderate to severe acne, prescription ...

Medication patches are available in a limited number of dosage strengths. Occasionally, some patients require a different dosage of a medication than the dosages commercially available in patch ...

Natural products are small molecules produced naturally by any organism including primary and secondary metabolites. They include very small molecules, such as urea, and complex structures ...

Danish biotechnology company Zealand Pharma said on Thursday it expected to initiate a so-called Phase 2b trial with its obesity treatment candidate petrelintide in the fourth quarter of 2024.